Pharmaceuticals, Biotechnology and Life Sciences
CLOSING OF THE STRATEGIC PARTNERSHIP WITH NEXTSTAGE AM EurobioNext holding becomes Eurobio Scientific’s new reference shareholder with a 28.3% holdingThe…
A Phase 1 Study Sponsored and Conducted by Veloxis Pharmaceuticals, Inc., the Company’s Partner in Transplantation NANTES, France, May 18,…
SOUTH SAN FRANCISCO, Calif., May 18, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company…
RESEARCH TRIANGLE PARK, N.C., May 18, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today…
NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE: BTTR) (the “Company” or “Better Choice”), a…
Dosing of the first subject in a Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the safety…
MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on innovative…
Yorktown Heights, N.Y., May 17, 2022 (GLOBE NEWSWIRE) — Akeso Therapeutics, Inc., an early-stage biotechnology company developing engineered natural killer…
EMERYVILLE, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to…